CA2871767C - Comprime comprenant une premiere et une seconde region - Google Patents

Comprime comprenant une premiere et une seconde region Download PDF

Info

Publication number
CA2871767C
CA2871767C CA2871767A CA2871767A CA2871767C CA 2871767 C CA2871767 C CA 2871767C CA 2871767 A CA2871767 A CA 2871767A CA 2871767 A CA2871767 A CA 2871767A CA 2871767 C CA2871767 C CA 2871767C
Authority
CA
Canada
Prior art keywords
tablet
region
powder blend
weight
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2871767A
Other languages
English (en)
Other versions
CA2871767A1 (fr
Inventor
Harry S. Sowden
Gerard P. Mcnally
Oliver Anderson
William J. Stuhl
Jen-Chi Chen
Kenneth Day
Christopher E. Szymczak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Publication of CA2871767A1 publication Critical patent/CA2871767A1/fr
Application granted granted Critical
Publication of CA2871767C publication Critical patent/CA2871767C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Dans un aspect, l'invention concerne un comprimé comprenant une première et une seconde région, dans lequel : (i) la première région et la seconde région comprennent chacune au moins 10 %, en volume, du comprimé ; (ii) la première région comprend un agent pharmaceutiquement actif et la composition de la première région est différente de la composition de la seconde région ; (iii) la première région a une masse volumique inférieure à environ 0,8 g/cc ; et (iv) la première région se désintègre dans la bouche lorsqu'elle est placée sous la langue en moins d'environ 30 secondes ; la forme du comprimé comprend deux faces principales opposées séparées par une paroi latérale, et l'interface entre la première région et la seconde région se trouve le long d'au moins une face principale du comprimé.
CA2871767A 2012-05-01 2013-05-01 Comprime comprenant une premiere et une seconde region Active CA2871767C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261640910P 2012-05-01 2012-05-01
US61/640,910 2012-05-01
US201261704767P 2012-09-24 2012-09-24
US61/704,767 2012-09-24
US13/804,109 2013-03-14
US13/804,109 US20130295174A1 (en) 2012-05-01 2013-03-14 Tablet comprising a first and second region
PCT/US2013/039045 WO2013166136A1 (fr) 2012-05-01 2013-05-01 Comprimé comprenant une première et une seconde région

Publications (2)

Publication Number Publication Date
CA2871767A1 CA2871767A1 (fr) 2013-11-07
CA2871767C true CA2871767C (fr) 2020-07-21

Family

ID=49512693

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2871767A Active CA2871767C (fr) 2012-05-01 2013-05-01 Comprime comprenant une premiere et une seconde region

Country Status (4)

Country Link
US (1) US20130295174A1 (fr)
EP (1) EP2844221B1 (fr)
CA (1) CA2871767C (fr)
WO (1) WO2013166136A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9610224B2 (en) 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
MX368159B (es) 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
US9839212B2 (en) 2015-04-16 2017-12-12 Bio-Lab, Inc. Multicomponent and multilayer compacted tablets
CA3044867A1 (fr) * 2016-11-28 2018-05-31 Gerard P. Mcnally Procede de fabrication d'une forme posologique revetue
US20200276087A1 (en) * 2017-09-21 2020-09-03 Hoffmann-La Roche Inc. Pharmaceutical manufacturing installation and method of manufacturing of a pharmaceutical product
DE202022001419U1 (de) 2022-06-22 2022-07-12 Agron Hasani Anordnung zur sachgerechten Darreichung von Nahrungsergänzungsmitteln

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US4824677A (en) * 1986-12-18 1989-04-25 The Unjohn Company Grooved tablet for fractional dosing of sustained release medication
US4851226A (en) 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4906478A (en) 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5275822A (en) 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
US5075114A (en) 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2068402C (fr) 1991-06-14 1998-09-22 Michael R. Hoy Enrobage pour masquer le gout pouvant etre utilise dans des comprimes pharmaceutiques croquables
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
EP1599186B1 (fr) * 2003-02-24 2013-04-10 Pharmaceutical Productions Inc. Systeme d'administration de medicaments par voie transmuqueuse
US20070184111A1 (en) * 2006-02-03 2007-08-09 Pharmavite Llc Hybrid tablet
EP2015779A2 (fr) * 2006-05-02 2009-01-21 Panacea Biotec Ltd Composition transmucosale
US9610224B2 (en) 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
WO2012039788A1 (fr) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Comprimé orodispersible multicouche et sa fabrication

Also Published As

Publication number Publication date
WO2013166136A1 (fr) 2013-11-07
EP2844221A1 (fr) 2015-03-11
US20130295174A1 (en) 2013-11-07
CA2871767A1 (fr) 2013-11-07
EP2844221B1 (fr) 2020-07-01

Similar Documents

Publication Publication Date Title
CA2871914C (fr) Machine de production de formes de dosage solides
CA2871769C (fr) Procede de fabrication de forme de dosage solide
EP2480201B1 (fr) Fabrication de comprimé dans une matrice à l'aide de mélange pulvérulent contenant une matière contenant de l'eau
CA2809050C (fr) Comprime orodispersible multicouche et sa fabrication
CA2871767C (fr) Comprime comprenant une premiere et une seconde region
AU2011306065A1 (en) Manufacture of tablets from energy-applied powder blend

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180320